Trial
NCT00750334
A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Genzyme, a Sanofi Company
Collaborators
—
Condition
Myelodysplastic Syndromes
Intervention
clofarabine
Why stopped
Terminated to focus on comparable trial, CLOMDS02507
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-21